NCT06248476Recruiting

Intermittent Theta Burst Stimulation and Repetitive Transcranial Magnetic Stimulation Combined With Robotic Rehabilitation on Ambulation in Spinal Cord Injury Patients

Name: Clinical Trial NCT06248476
Creator: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Keywords: Spinal Cord Injuries, Transcranial Magnetic Stimulation, device, clinical trial, Turkey

Effect of Intermittent Theta Burst Stimulation and Repetitive Transcranial Magnetic Stimulation Combined With Robotic Rehabilitation on Ambulation and Lower Extremity Motor Function in Chronic Spinal Cord Injury Patients

Gaziler Physical Medicine and Rehabilitation Education and Research HospitalClinicalTrials.govdeviceDevice trial

Verified

Study focus

Disease/Condition: Spinal Cord Injuries
Drug/Device/Intervention: Transcranial Magnetic Stimulation
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Location: Ankara, Turkey

Timeline & enrollment

Phase: N/A
Start date: Mar 01, 2023
End date: Jul 01, 2024
Enrollment: 30 participants

Primary outcome

Lower extremity motor score

Summary

Comparison of different types of transcranial magnetic stimulation techniques which are intermittent theta burst stimulation (iTBS) and high frequency repetitive transcranial magnetic stimulation (rTMS) in patients with spinal cord injury

ICD-10 classifications

Sequelae of injury of spinal cordOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06248476
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06248476 through Pure Global AI's free database. This phase not specified trial is sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.